South Korea and Australia on the rise as clinical research hubs
Novotech’s vice president highlighted the APAC region’s growing clinical presence, drawing attention to Australia and South Korea.
Novotech FDA WP
FDA approves Merck’s WINREVAIR for pulmonary arterial hypertension
FDA approves Madrigal’s Rezdiffra as the first NASH therapy
FDA doubles down on patient engagement to support rare disease research
FDA approves Allecra’s EXBLIFEP for cUTI treatment
Gilead’s Biktarvy gains FDA expanded indication approval for HIV
Bayer wins FDA breakthrough therapy designation for NSCLC candidate
FDA to decide on Sanofi/Regeneron’s Dupixent for COPD in June
